PENN-CHOP Blood Center for Patient Care and Discovery 2016-2018

PENN-CHOP Blood Center for Patient Care and Discovery 2016-2018

PENN-CHOP Blood Center for Patient Care and Discovery 2016-2018

Sessions

Topic Session datesort icon
Chimeric Antigen Receptors-Beyond the Realm of Cancer 1/6/16
Novel mechanisms for biased activation of protease activated receptors. 1/13/16
Hematopoietic cell engineering, disease modeling, and drug discovery using induced pluripotent stem cells 1/20/16
Perioperative Management of Patients on Warfarin or NOACs: Is heparin bridging needed? Perioperative NOAC management? 1/27/16
Discovery of a dedicated delivery system leads to an expanding universe of mammalian iron-sulfur proteins 2/10/16
Management of Pediatric ITP: Evidence versus Experience 2/24/16
The factor VIII life cycle: life in the shadow of a big brother. 3/2/16
Sub-segmental pulmonary embolism: To treat or not to treat. 3/9/16
Inhibitors in mild and moderate hemophilia A: Not so mild after all 3/23/16
Self-renewal of human hematopoietic progenitor cells: From the clinic to the laboratory and back to the clinic 3/30/16
Basic and translational studies of extracellular DNA and histones in sepsis 4/6/16
Sickle Cell Trait: Novel Insights into a Forgotten Carrier State 4/13/16
Reversing oral Anticoagulants in 2016 4/27/16
The Cardiomyopathy of Sickle Cell Disease 5/4/16
Protein disulfide isomerase as an antithromboitc target 5/11/16
Genetic Factors modifying sickle cell disease severity 5/18/16
Engineering in vitro micro-technologies to investigate hematologic processes and disorders 5/25/16
Coagulopathy of cirrhosis and transfusion management 6/1/16
Delivery of thrombomodulin by carrier erythrocytes: addressing translational challenges 6/8/16
Prothrombotic state in sickle cell disease 6/22/16
When Watson and Crick Get Linked: DNA Interstrand Crosslink Repair and Human Disease 9/28/16
Mechanisms Governing Hematopoietic Stem and Progenitor Cell Transitions 10/12/16
The iron-regulatory hormone hepcidin: new biology and clinical application. 10/26/16
Research Updates: Health Outcomes in Patients with Sickle Cell Disease 11/2/16
The role of pleckstrin-2 in the pathogenesis of JAK2 V617F induced MPNs 11/9/16
Gene Therapy for Monogenic Diseases: Current Successes and Future Applicaitons 11/16/16
Progress in Gene Therapy for Hemophilia 12/14/16
Intravenous Iron for Iron Deficiency Anemia: A New Paradigm 1/4/17
Adverse effects of red blood cell transfusions 1/11/17
Life-long hematopoiesis is established by hundreds of precursors throughout mammalian ontogeny 1/18/17
Transfusion of the critically ill at the University of Pennsylvania: Lessons from Kampala 1/25/17
RBC Junctions: Implications for Trafficking and Cell Polarity 2/8/17
Immunoregulatory Networks in Alloimmunization 2/15/17
Therapeutic targeting of Myelodysplastic syndromes 2/22/17
Should cord blood transplantation remain only an alternative 3/1/17
Mitochondria in the Regulation of Blood-Forming Stem and Progenitor Cells; a FOXO3 Perspective 3/8/17
Making blood before a blood stem cell 4/5/17
Novel Vaccines for Pediatric Falciparum Malaria 4/12/17
Ex vivo megakaryopoiesis: a tool for translational research and beyond 4/26/17
Crosstalk between thrombosis, inflammation and innate immunity 5/10/17
Genomics in Pediatric Immune Thrombocytopenia: Challenges and Opportunities 5/17/17
Clinical Research Progress in a Rare Anemia: New Developments in Pyruvate Kinase Deficiency 5/24/17
Responsiveness and Non-Responsiveness to Red Blood Cell Antigens 5/31/17
Imaging Innate Immunity In Vivo 6/7/17
Cancer-Associated Venous Thromboembolism 6/28/17
Oxygen and Erythropoiesis 10/4/17
Current Challenges in the Diagnosis and Management of TTP 10/18/17
Coagulation disorders: fishing for new diagnostics and therapeutics 10/25/17
Gene therapy approaches for beta-hemoglobinopathies 11/1/17
Reversal of Oral Anticoagulants 11/15/17
Role of innate immune signaling in myelodsyplasia 11/29/17
Pathogenesis of acquired aplastic anemia and its clonal complications 12/6/17
Editing the genome and epigenome to treat hemoglobinopathies 12/20/17
Emerging Non-Factor Treatments for Hemophilia 1/10/18
Regulation of stress erythropoiesis by inflammation 1/17/18
Fetal and Neonatal Alloimmune Thrombocytopenia 1/24/18
Epigenetic regulation of embryonic hematopoiesis by TET proteins 1/31/18
Bidirectional interactions between hemostasis and glomerular biology 2/7/18
The Pathophysiology of Diamond Blackfan anemia (DBA) and myelodysplastic syndrome (MDS) 2/21/18
Deciphering Specialized Pathways for Erythroid Iron Sensing and Metabolism 2/28/18
Differentiate Me: Novel approaches to targeting hematologic malignancies 3/7/18
Lessons Learned from Transfusion Medicine 3/28/18
Improving Therapeutic Apheresis Practice Using the Guidelines of the American Society of Apheresis 4/11/18
Therapeutics for Modulating Blood Coagulation and Systemic Iron Excretion 4/25/18
Evolution of Antithrombotic Therapy: A Personal Journey 5/30/18
A Cell for all Seasons: Macrophages in Health and Disease 6/6/18
Thrombotic Microangiopathy (TMA): Lesson from Zebrafish to Human. 6/13/18
Is Routine Coagulation Testing Useful? 6/20/18
GATA1 deficiencies in human erythroid and megakaryocytic disorders 10/3/18
Lessons from Bloodless Worms: Heme Trafficking in Eukaryotes 10/10/18
Office of Continuing Medical and Interprofessional Education
150 Anatomy/Chemistry Building, 3620 Hamilton Walk
Philadelphia, PA 19104-6061
Contact us: penncme@pennmedicine.upenn.edu | 215-898-8005
© The Trustees of the University of Pennsylvania
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.